Company Filing History:
Years Active: 2019
Title: Minyun Zhou: Innovator in Insulin Receptor Modulation
Introduction
Minyun Zhou is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of insulin receptor modulators. His innovative work has the potential to impact the treatment of diabetic conditions.
Latest Patents
Minyun Zhou holds a patent for "Stabilized Polypeptide Insulin Receptor Modulators." This patent describes stabilized α-CT polypeptides that include an alpha-helical segment. The polypeptides are designed to bind to the insulin receptor and include at least one staple or stitch formed by cross-linked amino acids. The patent also covers insulin analogs that incorporate these polypeptides, along with pharmaceutical compositions and methods for treating diabetes and its complications.
Career Highlights
Minyun Zhou is affiliated with Harvard College, where he conducts research and develops innovative solutions in the field of insulin modulation. His work is characterized by a strong focus on enhancing the stability and efficacy of insulin receptor interactions.
Collaborations
Minyun Zhou has collaborated with esteemed colleagues such as Gregory Lawrence Verdine and Gerard Hilinski. These partnerships have contributed to the advancement of his research and the development of new therapeutic approaches.
Conclusion
Minyun Zhou's contributions to the field of insulin receptor modulation exemplify the importance of innovation in medical science. His work not only advances our understanding of insulin interactions but also holds promise for improving diabetes treatment.